AUROBINDO PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 19.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 19.3%
Tue, 12 Feb

AUROBINDO PHARMA has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

AUROBINDO PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m43,36147,51452,69710.9%21.5%
Other incomeRs m331263639143.1%93.2%
TurnoverRs m43,69247,77753,33511.6%22.1%
ExpensesRs m33,10537,65141,83311.1%26.4%
Gross profitRs m10,2589,59410,61310.6%3.5%
DepreciationRs m1,3811,6371,631-0.3%18.1%
InterestRs m18935447734.6%152.7%
Profit before taxRs m9,0207,8669,14416.2%1.4%
TaxRs m3,0691,7542,04816.7%-33.3%
Profit after taxRs m5,9506,1127,09616.1%19.3%
Gross profit margin%23.720.220.1
Effective tax rate%34.022.322.4
Net profit margin%13.612.813.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 21.5% on a year-on-year (YoY) basis. The expenses were up by 26.4% YoY during the same period.
  • The company's operating profit increased by 3.5% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 20.1% in 3QFY19 as against 23.7% in 3QFY18.
  • Depreciation charges increased by 18.1% and finance costs increased by 152.7% YoY, respectively.
  • Other income increased by 93.2% YoY during the quarter.
  • Net profit for the quarter increased by 19.3% YoY. Net profit margins during the quarter declined from 13.6% in 3QFY18 to 13.3% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 10.9% on a quarter-on-quarter (QoQ) basis. The expenses were up by 11.1% QoQ during the same period.
  • The company's operating profit declined by 10.6% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 20.1% in 3QFY19 as against 20.2% in 2QFY18.
  • Net profit for the quarter increased by 16.1% QoQ, while net profit margins increased from 12.8% in 2QFY18 to 13.3% in 3QFY19.

To see how AUROBINDO PHARMA has performed over the last eight quarters, please visit here.

AUROBINDO PHARMA Share Price Performance

Over the last one year, AUROBINDO PHARMA share price has moved up from Rs 607.9 to Rs 766.0, registering a Gain of Rs 158.2 or around 26.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,712.7 (down 0.1%). Over the last one year it has moved down from 14,517.2 to 13,712.7, a gain of 805 points (down 5.5%).

Overall, the S&P BSE SENSEX is up 6.1% over the year.

Current Valuations

At the current price of Rs 766.0, the price to earnings (P/E) ratio of AUROBINDO PHARMA stands at 19.5 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.8 times.

Equitymaster requests your view! Post a comment on "AUROBINDO PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 19.3%". Click here!

  

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 0.5% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (down 0.5% YoY). Sales on the other hand came in at Rs 58 bn (up 10.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 4.6% YoY). Sales on the other hand came in at Rs 56 bn (up 17.9% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks(Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years)(Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Here's Why I Recommended 15 Stocks in One Day Flat(Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

The Top 8 Trading Mistakes You Should Avoid(Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

These Rebirth of India Stocks Are Raring to Compete with Tesla(The 5 Minute Wrapup)

Feb 17, 2020

There are Indian stocks which can soar like Tesla in the long-run.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Feb 20, 2020 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS